-
Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells
van Spronsen, M. F., van Gassen, S., Duetz, C., Westers, T. M., Saeys, Y. & van de Loosdrecht, A. A., Jun 2024, In: Leukemia. 38, 6, p. 1365-1377 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
van de Loosdrecht, A. A., Cremers, E. M. P., Alhan, C., Duetz, C., in ’t Hout, F. E. M., Visser-Wisselaar, H. A., Chitu, D. A., Verbrugge, A., Cunha, S. M., Ossenkoppele, G. J., Janssen, J. J. W. M., Klein, S. K., Vellenga, E., Huls, G. A., Muus, P., Langemeijer, S. M. C., de Greef, G. E., te Boekhorst, P. A. W., Raaijmakers, M. H. G., van Marwijk Kooy, M., & 20 others, Apr 2024, In: Leukemia. 38, 4, p. 840-850 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
Janssen, L. L. G., Westers, T. M., Rovers, J., Valk, P. J. M., Cloos, J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2 Nov 2023, In: HemaSphere. 7, 11, p. E968Research output: Contribution to journal › Letter › Academic › peer-review
- All publications
